Reference is made to the stock exchange announcement by
As further described in the Announcement, the Private Placement consists of two tranches, of which tranche 1 comprises 38,137,038 offer shares ("Tranche 1") and tranche 2 comprises 16,862,962 offer shares ("Tranche 2"), the latter subject to a resolution by the extraordinary general meeting of the Company to issue the new shares allocated to investors in Tranche 2.
To facilitate delivery-versus-payment settlement in the Private Placement, Ingerø Reiten Investment Company AS and ELI AS(jointly the "Share Lenders") have agreed to lend existing shares in the Company to
Ingerø Reiten Investment Company AS has lent to the Settlement Agent 37,300,000 shares in the Company to facilitate settlement of Tranche 1. Prior to such share lending, Ingerø Reiten Investment Company AS holds 37,384,437 shares in the Company (representing approximately 19.61% of the issued share capital and votes). During the term of the lending of said shares, Ingerø Reiten Investment Company AS' shareholding in the Company will be reduced to 84,437 shares, representing approximately 0.04% of the shares and votes in the Company. Consequently, Ingerø Reiten Investment Company AS' shareholding has fallen below the 5.00% threshold pursuant to Section 4-2 (1) cf. (3) of the Norwegian Securities Trading Act.
This information is subject to disclosure requirements pursuant to Article 19 of Regulation EU 596/2014 (the EU Market Abuse Regulation) and Sections 4-2 and 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Jørgen Mann, Interim CEO
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About
The Company seeks to drive growth by leveraging its expertise in sales and commercialisation of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution.
The Company is headquartered in
Further information is available at www.observemedical.com.
https://news.cision.com/observe-medical-asa/r/observe-medical-asa--disclosure-of-share-lending-by-persons-closely-associated-with-primary-insiders,c4005813
https://mb.cision.com/Public/19175/4005813/98352eebd99f2551.pdf
(c) 2024 Cision. All rights reserved., source